Used primarily in cancer research, this compound acts as an inhibitor targeting the c-Met receptor tyrosine kinase. It is applied in studies to understand and disrupt signaling pathways involved in tumor growth and metastasis. Researchers utilize it to explore potential therapeutic strategies for cancers where c-Met overexpression or mutation plays a critical role, such as in certain types of lung, liver, and gastric cancers. Its ability to block c-Met activity helps in assessing the receptor's role in cancer progression and in evaluating the efficacy of targeted treatments.